Detection of immunoglobulin heavy chain gene rearrangements in hematologic malignancies

Expert Review of Molecular Diagnostics
B Gleissner, E Thiel

Abstract

B-cell precursors undergo a unique somatic immunoglobulin heavy chain gene rearrangement process. The generated VHDHJH junction is a successful marker in lymphoproliferative malignancies at initial diagnosis for detection of clonality and during treatment for monitoring minimal residual disease. VHDHJH errors are often involved in recurring structural chromosomal aberrations of lymphoid malignancies, with consequent deregulated expression of the juxtaposed oncogenes, e.g., c-myc, bcl-2 or CCND1. Besides cytogenetics, a variety of molecular techniques are becoming increasingly established, including Southern blotting, PCR and real-time PCR, as well as fluorescence in situ hybridisation. Different approaches may be chosen to evaluate lymphoid malignancies either at diagnosis or follow-up in the light of increasing relevance and proven clinical utility.

References

Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C M CroceH Koprowski
Jan 15, 1976·International Journal of Cancer. Journal International Du Cancer·L ZechG Klein
Dec 1, 1991·American Journal of Clinical Pathology·M E WilliamsC Y Thomas
Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·M L ClearyJ Sklar
May 1, 1982·The Journal of Experimental Medicine·O W McBrideP Leder

❮ Previous
Next ❯

Citations

Aug 5, 2004·Current Oncology Reports·Adam Bagg
Jan 9, 2004·Expert Review of Molecular Diagnostics·Adam Bagg

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.